Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Hypoxia-inducible factor (HIF) is a transcriptional complex that plays a central role in the regulation of gene expression by oxygen. In oxygenated and iron replete cells, HIF-alpha subunits are rapidly destroyed by a mechanism that involves ubiquitylation by the von Hippel-Lindau tumor suppressor (...

Bibliografiset tiedot
Päätekijät:	Jaakkola, P, Mole, D, Tian, Y, Wilson, M, Gielbert, J, Gaskell, S, von Kriegsheim, A, Hebestreit, H, Mukherji, M, Schofield, C, Maxwell, P, Pugh, C, Ratcliffe, P
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	2001

Samankaltaisia teoksia

Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein.
Tekijä: Cockman, M, et al.
Julkaistu: (2000)

Regulation of HIF by the von Hippel-Lindau tumour suppressor: implications for cellular oxygen sensing.
Tekijä: Mole, D, et al.
Julkaistu: (2001)

Chemical basis for the selectivity of the von Hippel Lindau tumor suppressor pVHL for prolyl-hydroxylated HIF-1alpha.
Tekijä: Illingworth, C, et al.
Julkaistu: (2010)

Interaction of hydroxylated collagen IV with the von hippel-lindau tumor suppressor.
Tekijä: Grosfeld, A, et al.
Julkaistu: (2007)

The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis.
Tekijä: Pugh, C, et al.
Julkaistu: (2003)

C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation.
Tekijä: Epstein, A, et al.
Julkaistu: (2001)

Regulation of the HIF pathway: enzymatic hydroxylation of a conserved prolyl residue in hypoxia-inducible factor alpha subunits governs capture by the pVHL E3 ubiquitin ligase complex.
Tekijä: Mole, D, et al.
Julkaistu: (2002)

Selection of mutant CHO cells with constitutive activation of the HIF system and inactivation of the von Hippel-Lindau tumor suppressor.
Tekijä: Vaux, E, et al.
Julkaistu: (2001)

Insights into the role of the von Hippel-Lindau gene product. A key player in hypoxic regulation.
Tekijä: Maxwell, P, et al.
Julkaistu: (2001)

Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma.
Tekijä: Raval, R, et al.
Julkaistu: (2005)

2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase.
Tekijä: Mole, D, et al.
Julkaistu: (2003)

Regulation of HIF: prolyl hydroxylases.
Tekijä: Stolze, I, et al.
Julkaistu: (2006)

Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease.
Tekijä: Clifford, S, et al.
Julkaistu: (2001)

Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylases.
Tekijä: Schlemminger, I, et al.
Julkaistu: (2003)

A new von Hippel-Lindau disease
Tekijä: Ratcliffe, P
Julkaistu: (2003)

Determination and comparison of specific activity of the HIF-prolyl hydroxylases.
Tekijä: Tuckerman, JR, et al.
Julkaistu: (2004)

The use of dioxygen by HIF prolyl hydroxylase (PHD1).
Tekijä: McNeill, L, et al.
Julkaistu: (2002)

Cardiopulmonary function in two human disorders of the hypoxia-inducible factor (HIF) pathway: von Hippel-Lindau disease and HIF-2α gain-of-function mutation.
Tekijä: Formenti, F, et al.
Julkaistu: (2011)

Tuning the transcriptional response to hypoxia by inhibiting HIF prolyl- and asparaginyl-hydroxylases
Tekijä: Chan, M, et al.
Julkaistu: (2016)

Mutation of von Hippel-Lindau tumour suppressor and human cardiopulmonary physiology.
Tekijä: Smith, T, et al.
Julkaistu: (2006)

Mutation of von Hippel-Lindau tumour suppressor and human cardiopulmonary physiology
Tekijä: Smith, T, et al.
Julkaistu: (2006)

Mutation of the von Hippel-Lindau gene alters human cardiopulmonary physiology.
Tekijä: Smith, T, et al.
Julkaistu: (2008)

Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation.
Tekijä: Masson, N, et al.
Julkaistu: (2001)

Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling.
Tekijä: Wykoff, C, et al.
Julkaistu: (2000)

Leu-574 of human HIF-1alpha is a molecular determinant of prolyl hydroxylation.
Tekijä: Kageyama, Y, et al.
Julkaistu: (2004)

Glucocorticoids promote Von Hippel Lindau degradation and Hif-1α stabilization
Tekijä: Vettori, A, et al.
Julkaistu: (2017)

Sindrom Von Hippel–Lindau
Julkaistu: (2011-06-01)

Von Hippel-Lindau Disease
Tekijä: Hes Frederik J, et al.
Julkaistu: (2005-11-01)

Von Hippel–Lindau disease
Tekijä: Juhara Haron, et al.
Julkaistu: (2017-04-01)

The von Hippel-Lindau tumor suppressor protein promotes c-Cbl-independent poly-ubiquitylation and degradation of the activated EGFR.
Tekijä: Liang Zhou, et al.
Julkaistu: (2011-01-01)

Genetic analysis of pathways regulated by the von Hippel-Lindau tumor suppressor in Caenorhabditis elegans
Tekijä: Bishop, T, et al.
Julkaistu: (2004)

Characterization of different isoforms of the HIF prolyl hydroxylase PHD1 generated by alternative initiation.
Tekijä: Tian, Y, et al.
Julkaistu: (2006)

Analysis of von Hippel-Lindau tumor suppressor as a mediator of cellular oxygen sensing.
Tekijä: Masson, N, et al.
Julkaistu: (2004)

Mutation of von Hippel-Lindau tumour suppressor and human cardiopulmonary physiology.
Tekijä: Thomas G Smith, et al.
Julkaistu: (2006-07-01)

Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
Tekijä: Chowdhury, R, et al.
Julkaistu: (2016)

Von Hippel-Lindau Disease and Pheochromocytoma
Tekijä: J Gordon Millichap
Julkaistu: (1993-12-01)

Von Hippel-Lindau disease (VHLD)
Tekijä: Jorge Luis González Jara
Julkaistu: (2009-09-01)

Von Hippel-Lindau Disease and the Eye
Tekijä: Saeed Karimi, et al.
Julkaistu: (2020-02-01)

Doença de Von Hippel-Lindau
Tekijä: Margarida Carvalho, et al.
Julkaistu: (2016-09-01)

Pheochromocytoma in von Hippel-Lindau disease
Tekijä: Petakov Milan, et al.
Julkaistu: (2003-01-01)